SMIN - ETF AI Analysis

Top Page

iShares MSCI India Small Cap ETF (SMIN)

Rating:59Neutral

Price Target:―

The iShares MSCI India Small Cap ETF (SMIN) has a moderate overall rating, reflecting a mix of strengths and challenges among its holdings. Embassy Office Parks REIT stands out as a key contributor due to its strong financial performance, reasonable valuation, and healthy dividend yield, which positively impact the fund's rating. However, weaker holdings like Glenmark Pharmaceuticals, with profitability volatility and bearish momentum, may have held back the ETF’s overall score. Investors should note the potential risks of overvaluation across several holdings and the concentration in small-cap Indian stocks, which can lead to higher volatility.

Positive Factors

Strong Sector Diversification

The ETF is spread across multiple sectors, including materials, healthcare, and financials, reducing reliance on any single industry.

Focused Geographic Exposure

With nearly all assets invested in India, the fund provides targeted exposure to a growing emerging market economy.

Healthy Top Holdings Performance

Several top holdings, such as Fortis Healthcare and Laurus Labs, have shown strong year-to-date gains, supporting the fund’s potential recovery.

Negative Factors

High Expense Ratio

The ETF charges a relatively high fee compared to many other funds, which can eat into investor returns over time.

Weak Overall Performance

The fund has struggled recently, with negative year-to-date and three-month returns, signaling potential challenges in the small-cap segment.

Over-Concentration in India

The ETF’s heavy focus on Indian stocks limits diversification and increases vulnerability to country-specific risks.

SMIN vs. SPDR S&P 500 ETF (SPY)

AUM832.51M

RegionAsia-Pacific

Expense Ratio0.75%

Beta0.51

IssueriShares

Inception DateFeb 08, 2012

Dividend Yield7.32%

Asset ClassEquity

Index TrackedMSCI India Small Cap

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume110,158

30 Day Avg. Volume150,877

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

SMIN Summary

The iShares MSCI India Small Cap ETF (SMIN) is an investment fund that focuses on small companies in India, offering exposure to the country’s fast-growing economy. It follows the MSCI India Small Cap Index, which includes businesses across various sectors like healthcare, financials, and technology. Some of its well-known holdings include Fortis Healthcare and Federal Bank. This ETF is ideal for investors looking to diversify their portfolio and tap into the growth potential of smaller, innovative companies in emerging markets. However, it’s important to note that small-cap stocks can be more volatile, meaning their value may rise and fall quickly.

How much will it cost me?The iShares MSCI India Small Cap ETF (SMIN) has an expense ratio of 0.75%, meaning you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because it is an actively managed fund focusing on small-cap stocks in India, which require more research and management compared to passively managed funds.

What would affect this ETF?The iShares MSCI India Small Cap ETF (SMIN) could benefit from India's strong economic growth and increasing innovation in sectors like technology and healthcare, which are key areas of exposure for the fund. However, risks include potential regulatory changes in India, global economic uncertainty, and the inherent volatility of small-cap stocks, which can be more sensitive to market fluctuations. Investors should also consider how interest rate changes or inflation could impact sectors like financials and consumer goods within the ETF.

SMIN Top 10 Holdings

The iShares MSCI India Small Cap ETF (SMIN) is a vibrant mix of India's small-cap stars, with notable strength in financials and healthcare. Federal Bank is rising steadily, buoyed by solid technical indicators, while Laurus Labs is gaining momentum thanks to robust revenue growth. On the flip side, Fortis Healthcare is lagging, weighed down by bearish trends, and KEI Industries is losing steam amid valuation concerns. With a broad exposure to India’s dynamic sectors, this fund offers a compelling but volatile ride through the country’s entrepreneurial heartbeat.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
COFORGE	Coforge Limited	1.76%	$14.94M	₹640.68B	9.70%	73 Outperform
MFSL	Max Financial Services Limited	1.36%	$11.54M	₹583.57B	53.72%	59 Neutral
FEDERALBNK	Federal Bank Ltd. (India)	1.36%	$11.54M	₹629.67B	23.17%	64 Neutral
EMBASSY	Embassy Office Parks REIT	1.05%	$8.94M	₹415.27B	19.00%	76 Outperform
LAURUSLABS	Laurus Labs Ltd.	1.05%	$8.89M	₹550.46B	75.66%	66 Neutral
GLENMARK	Glenmark Pharmaceuticals Limited	0.87%	$7.42M	₹558.60B	27.04%	53 Neutral
LTF	L&T Finance Ltd	0.79%	$6.72M	₹765.80B	110.38%	62 Neutral
360ONE	360 One Wam Limited	0.76%	$6.48M	₹471.08B	0.53%	65 Neutral
UNOMINDA	UNO Minda Limited	0.76%	$6.45M	₹744.53B	22.97%	66 Neutral
KEI	KEI Industries Limited	0.74%	$6.33M	₹399.77B	-3.64%	70 Outperform

SMIN Technical Analysis

Technical Analysis Sentiment

Negative

Last Price―

Price Trends

50DMA

73.24

Negative

100DMA

73.70

Negative

200DMA

72.08

Negative

Market Momentum

MACD

-0.44

Positive

RSI

38.74

Neutral

STOCH

34.10

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SMIN, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 72.96, equal to the 50-day MA of 73.24, and equal to the 200-day MA of 72.08, indicating a bearish trend. The MACD of -0.44 indicates Positive momentum. The RSI at 38.74 is Neutral, neither overbought nor oversold. The STOCH value of 34.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SMIN.

SMIN Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
SMIN	―	―	$832.51M	0.75%	―
INDA	―	―	$9.58B	0.62%	―
INDY	―	―	$695.35M	0.65%	―
PIN	―	―	$202.37M	0.78%	―
NFTY	―	―	$185.06M	0.80%	―
GIND	―	―	$106.80M	0.75%	―

Performance Comparison

SMIN

iShares MSCI India Small Cap ETF

71.46

-7.31

-9.28%

INDA

iShares MSCI India ETF

―

INDY

iShares India 50 ETF

―

Invesco India ETF

―

NFTY

First Trust India NIFTY 50 Equal Weight ETF

―

GIND

Goldman Sachs India Equity ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents